VANDERBILT UNIVERSITY MEDICAL CENTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1925-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.vumc.org
Biochemical and Radiological Indicators of Cardiovascular Morbidity in Children With Premature Pubarche
Completed
- Conditions
- Evidence of Cardiovascular Morbidity
- First Posted Date
- 2007-12-27
- Last Posted Date
- 2017-04-04
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 52
- Registration Number
- NCT00581490
- Locations
- 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States
Humanitarian Device Exemption
- Conditions
- Dystonia
- First Posted Date
- 2007-12-27
- Last Posted Date
- 2019-10-14
- Lead Sponsor
- Vanderbilt University Medical Center
- Registration Number
- NCT00580658
- Locations
- 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States
Characteristics of Glargine in Type 2 Diabetics
Phase 1
Completed
- Conditions
- Type 2 Diabetes
- Interventions
- Drug: PlaceboDrug: Insulin Glargine 0.5 u/kg body wt SCDrug: Insulin Glargine 1.0 u/kg body wt SCDrug: Insulin Glargine 1.5 u/kg body wt SCDrug: Insulin Glargine 2.0 u/kg body wt SC
- First Posted Date
- 2007-12-17
- Last Posted Date
- 2017-04-17
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT00574912
- Locations
- 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States
Physiological Brain Atlas Development
Recruiting
- Conditions
- Parkinson's DiseaseDystoniaEpilepsyEssential TremorObsessive Compulsive Disorder
- Interventions
- Device: Stereotactic brain procedures
- First Posted Date
- 2007-12-17
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 5000
- Registration Number
- NCT00575081
- Locations
- 🇺🇸
Vanderbilt Univeristy, Nashville, Tennessee, United States
Neurocognitive Functioning in Patients With Newly Diagnosed Upper Aerodigestive Tract Cancer Receiving Treatment at Henry-Joyce Cancer Clinic
Completed
- Conditions
- Esophageal CancerHead and Neck CancerLung CancerNeurocognitive ImpairmentDelirium
- Interventions
- Other: Assessment of therapy complicationsOther: Neurocognitive assessmentOther: Quality-of-life assessment
- First Posted Date
- 2007-09-24
- Last Posted Date
- 2017-04-07
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 86
- Registration Number
- NCT00533884
- Locations
- 🇺🇸
MBCCOP - Meharry Medical College - Nashville, Nashville, Tennessee, United States
🇺🇸Vanderbilt-Ingram Cancer Center at Franklin, Nashville, Tennessee, United States
🇺🇸Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville, Tennessee, United States
Protein and Phospholipid Analysis of HDL in Patients With Very High Serum Levels of HDL-C
Terminated
- Conditions
- Hyperlipidemia
- First Posted Date
- 2007-09-05
- Last Posted Date
- 2017-04-04
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 19
- Registration Number
- NCT00525083
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Elevated Serum HDL in Four Generations of a Nashville Family
Terminated
- Conditions
- Hyperlipidemias
- Interventions
- Other: No Intervention
- First Posted Date
- 2007-09-05
- Last Posted Date
- 2017-03-20
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 3
- Registration Number
- NCT00525109
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
ExploR™ Modular Radial Head Data Collection
Active, not recruiting
- Conditions
- Elbow Fracture
- Interventions
- Device: Biomet Explor Modular Radial Head Replacement
- First Posted Date
- 2007-08-28
- Last Posted Date
- 2025-02-17
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT00521846
- Locations
- 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States
Endoscopic Ultrasound (EUS) Guided Treatment With Humira for Crohn's Perianal Fistulas
Phase 4
Completed
- Conditions
- Crohn DiseaseRectal Fistula
- Interventions
- First Posted Date
- 2007-08-16
- Last Posted Date
- 2017-04-21
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 21
- Registration Number
- NCT00517296
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Diurnal Variation of Plasminogen Activator Inhibitor-1
Phase 4
Completed
- Conditions
- Metabolic Syndrome X
- Interventions
- First Posted Date
- 2007-08-13
- Last Posted Date
- 2019-02-01
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 21
- Registration Number
- NCT00515021
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
© Copyright 2025. All Rights Reserved by MedPath